HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dlamini, Z Articles by Bhoola, K D Search for Related Content PubMed PubMed Citation Articles by Dlamini, Z Articles by Bhoola, K D Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Esophageal Cancer Related Collections Histopathology Esophagus Molecular Medicine Cancer: gastroenterological

Upregulation of tissue kallikrein, kinin B₁ receptor, and kinin B₂ receptor in mast and giant cells infiltrating oesophageal squamous cell carcinoma

¹ School of Anatomical Sciences, University of the Witwatersrand, Faculty of Health Sciences, 7 York Road, Parktown, Johannesburg, 2193, South Africa
² Asthma and Allergy Institute, School of Medicine and Pharmacology, Sir Charles Gaidner Hospital, University of Western Australia, Nedlands WA 6009, Australia

Correspondence to:
Dr Z Dlamini
School of Anatomical Sciences, University of the Witwatersrand, Faculty of Health Sciences, 7 York Road, Parktown, Johannesburg, 2193, South Africa; dlaminiz{at}anatomy.wits.ac.za Background: The mitogenic kinin peptides formed by the serine protease, tissue kallikrein (TK1), stimulate the proliferation of tumour cells and, by increasing vascular permeability, enhance metastasis. Oesophageal mucosal epithelial cells are derived from the epithelial cell germ layer, which expresses the kallikrein–kinin cascade.

Aim: To determine the cellular distribution of active TK1, prokallikrein, and the kinin B₁ and B₂ receptors in oesophageal carcinoma by immunocytochemistry and in situ hybridisation (ISH).

Methods: Fifty oesophageal specimens (33 biopsies and 17 resections) and 10 control specimens adjacent to tumour or normal oesophageal biopsies were studied. Specific antibodies were used to determine the cellular localisation of TK1, prokallikrein, and the kinin B₁ and B₂ receptors in normal and oesophageal specimens by standard immunohistochemical techniques. The intensity of immunolabelling was quantified by image analysis. Antisense probes for TK1 and the kinin B₁ and B₂ receptors were also used to localise mRNA.

Results: TK1 (active and prokallikrein) was expressed in the mucosa of normal and tumour oesophageal epithelium. In general, expression was highest in activated mast cells, followed by giant tumour cells. Immunolabelling results were confirmed by ISH experiments.

Conclusions: This is the first demonstration that TK1 and kinin B₁ and B₂ receptors are expressed in oesophageal carcinoma. Because TK1 released from tumour cells enzymatically generates mitogenic kinins from its endogenous substrate, kininogen, it is possible that third generation kinin receptor antagonists, which have been shown to be cytotoxic to cancer cells, may be useful therapeutic agents in this disease.

Abbreviations: DAB, diaminobenzidine; DIG, digoxygenin; HUK, human urinary kallikrein; PBS, phosphate buffered saline; PCR, polymerase chain reaction; SSC, saline sodium citrate; TK, tissue kallikrein; rTK, recombinant tissue kallikrein; TProK, tissue prokallikrein

Keywords: tissue kallikrein; kinin B1and B2 receptors; oesophageal carcinoma; tissue prokallikrein; mast cells; giant tumour cells; kinins

This article has been cited by other articles:

				J. Duchene, F. Lecomte, S. Ahmed, C. Cayla, J. Pesquero, M. Bader, M. Perretti, and A. Ahluwalia A Novel Inflammatory Pathway Involved in Leukocyte Recruitment: Role for the Kinin B1 Receptor and the Chemokine CXCL5 J. Immunol., October 1, 2007; 179(7): 4849 - 4856. [Abstract] [Full Text] [PDF]